Effect of dutasteride on androgen-response gene expression during the tumor regrowth phase of intermittent androgen ablation therapy in patients with advanced prostate cancer.
Phase of Trial: Phase II
Latest Information Update: 13 Feb 2014
At a glance
- Drugs Dutasteride (Primary)
- Indications Prostate cancer
- Focus Pharmacogenomic; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 16 Feb 2013 Results presented at the 2013 Genitourinary Cancers Symposium.
- 24 Jan 2013 New source identified and integrated (Robert H. Lurie Comprehensive Cancer Center record: NU-E08U1).
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History